Planet Labs (PL) Rule 144 Notice: Insider Plans Sale of 422,335 Warrants

Rhea-AI Filing Summary

This Form 144 notice reports a proposed sale of 422,335 warrants by Isalea Investments LP, with an aggregate market value of $846,021.47. The warrants represent part of 12,833,315 outstanding units and the approximate sale date is 09/16/2025 on the NYSE. The filer acquired the warrants as founder stock from the issuer on 03/05/2021 and records the original payment as cash. The filing also discloses two recent warrant sales by the same account in the prior three months: 169,694 warrants sold on 09/12/2025 for $339,727.39, and 10,000 warrants sold on 08/19/2025 for $10,217.00. The signer affirms there is no undisclosed material adverse information.

Positive

• Rule 144 disclosure filed, providing transparency on proposed insider-related warrant sales
• Acquisition details provided (acquired 03/05/2021 as founder stock), clarifying provenance of the securities
• Recent sale history disclosed (10,000 on 08/19/2025 and 169,694 on 09/12/2025), aiding market transparency

Negative

• Proposed sale equals approximately 3.29% of outstanding warrants (422,335 of 12,833,315), which increases potential near-term supply
• Multiple recent sales in the past three months could signal ongoing liquidation activity by the holder

Insights

Securities Analyst

TL;DR: Insider-related sale of warrants representing a modest share of outstanding units; relevant for supply-side monitoring.

The filing documents a Rule 144 notice for the disposition of 422,335 warrants by Isalea Investments LP, valued at $846k, with an intended execution on 09/16/2025 on the NYSE. The securities were acquired as founder stock on 03/05/2021. Recent sales of 169,694 and 10,000 warrants in Aug–Sep 2025 are reported, indicating staged liquidation activity. For investors and analysts tracking potential share supply and dilution risk from derivative exercises or secondary sales, these notices are useful signals. The filing contains no financial performance data or issuer-specific operational information.

Corporate Governance Specialist

TL;DR: Proper Rule 144 disclosure filed; no assertions of undisclosed adverse information by the seller.

The filer certifies compliance with Rule 144 reporting requirements and affirms absence of undisclosed material adverse information. Acquisition details show founder-originated warrants and cash payment. The staged sales disclosed in the prior three months suggest compliance with aggregation rules. There are no indications of trading-plan dates or 10b5-1 plan adoption in the filing. From a governance perspective, the form meets the routine transparency expectations for insider-related dispositions but does not provide additional context on motives or plan timing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Warrant	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	422335	846021.47	12833315	09/16/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Warrant	03/05/2021	Founder Stock	Issuer			422335	03/05/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ISALEA INVESTMENTS LP 645 Harrison Street Floor 4 SAN FRANCISCO CA 94107	Warrant	09/12/2025	169694	339727.39
ISALEA INVESTMENTS LP 645 Harrison Street Floor 4 SAN FRANCISCO CA 94107	Warrant	08/19/2025	10000	10217.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What quantity of warrants is Isalea Investments LP proposing to sell for PL?

The notice reports a proposed sale of 422,335 warrants with an aggregate market value of $846,021.47.

When is the approximate sale date and where will the warrants be sold?

The approximate date of sale is 09/16/2025 and the exchange listed is the NYSE.

How and when were the warrants being sold acquired?

The warrants were acquired as founder stock from the issuer on 03/05/2021, with cash recorded as the payment.

Has the filer sold any of these securities recently?

Yes. The filing discloses sales of 169,694 warrants on 09/12/2025 for $339,727.39 and 10,000 warrants on 08/19/2025 for $10,217.00.

Does the filer state there is undisclosed material adverse information?

The signer represents by signature that they do not know of any material adverse information